2008
DOI: 10.1016/j.jaad.2008.01.006
|View full text |Cite
|
Sign up to set email alerts
|

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

15
321
4
10

Year Published

2009
2009
2017
2017

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 377 publications
(350 citation statements)
references
References 128 publications
15
321
4
10
Order By: Relevance
“…The main modifications included the exclusion of arthritis, and due to insufficient information, peripheral vascular disease, hearing impairment, and visual impairment. To reflect current literature on comorbidities in psoriasis without arthritis, PsA, and other chronic inflammatory rheumatic diseases (1,3,18,(22)(23)(24)(25)(26), we also determined the occurrence of hyperlipidemia and hypertension, cancer, autoimmune disorders, liver disease, and infections. The clinical database was used to identify comorbid conditions in both psoriasis without arthritis and PsA patients.…”
Section: Significance and Innovationsmentioning
confidence: 99%
See 1 more Smart Citation
“…The main modifications included the exclusion of arthritis, and due to insufficient information, peripheral vascular disease, hearing impairment, and visual impairment. To reflect current literature on comorbidities in psoriasis without arthritis, PsA, and other chronic inflammatory rheumatic diseases (1,3,18,(22)(23)(24)(25)(26), we also determined the occurrence of hyperlipidemia and hypertension, cancer, autoimmune disorders, liver disease, and infections. The clinical database was used to identify comorbid conditions in both psoriasis without arthritis and PsA patients.…”
Section: Significance and Innovationsmentioning
confidence: 99%
“…Most recently, a relationship between psoriasis and increased risk of myocardial infarction, cerebrovascular disease, and peripheral vascular (cardiovascular) disease has been reported (3)(4)(5). The observed excess risk appears to be greatest in younger patients and those with more severe psoriasis.…”
Section: Introductionmentioning
confidence: 99%
“…Some publications show that patients with psoriasis have a higher risk of developing systemic comorbidities such as metabolic syndrome, diabetes mellitus and cardiovascular diseases [1][2][3][4] . In contrast to this statement, other authors found no association between severe psoriasis and obesity or between obesity and cardiovascular mortality in their studies 5 .…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, there are hypotheses implicating the pathogen in triggering psoriasis [3]. There are also data concerning concurrent presentation of psoriasis and gastritis, duodenitis, celiac disease or inflammatory bowel disease [4][5][6]. A few authors have related psoriasis and disturbances of the incretory and excretory pancreatic functions and even acute pancreatitis [7][8][9].…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, pro-inflammatory factors upregulated in psoriasis, especially interleukin (IL) 18, are likely to increase risk of the metabolic syndrome [15]. Previous reports have endorsed an association between psoriasis and the metabolic syndrome or lipid abnormalities [6,16,17]. Furthermore, psoriasis is believed to be an independent risk factor for subclinical atherosclerosis [6].…”
Section: Introductionmentioning
confidence: 99%